Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Strand

Showing results (11-20 of 150) with videos related to

Pageof 15
Sort By:
Current Opinion in Rheumatology|September 30, 1999
Biologic agents and innovative interventional approaches in the management of systemic lupus erythematosusV Strand
Clinical and Experimental Rheumatology|November 2, 1999
Steroid withdrawal favours joint erosion in rheumatoid arthritisV Strand
Lupus|April 24, 2001
Monoclonal antibodies and other biologic therapiesV Strand
The Journal of Rheumatology|July 1, 1995
OMERACT II: the biologics perspectiveV Strand
Springer Seminars in Immunopathology|July 18, 2001
New therapies in development for autoimmune diseases: their rationale for combination treatmentV Strand
Bailliere'S Clinical Rheumatology|November 1, 1995
Innovative treatment approaches for rheumatoid arthritis. Issues in clinical trials of biological agentsV Strand
Current Rheumatology Reports|December 26, 2001
Radiography of rheumatoid arthritis in the time of increasing drug effectivenessF Wolfe, V Strand
Rheumatology (Oxford, England)|March 18, 2004
Efficacy and safety of leflunomide 10 mg versus 20 mg once daily in patients with active rheumatoid arthritis: multinational double-blind, randomized trialG Poór, V Strand,
Internal Medicine Journal|October 15, 2013
Biosimilars: how similar?V Strand, B Cronstein
Bulletin on the Rheumatic Diseases|January 1, 1979
Advances in the diagnosis and concept of Sjögren's syndrome (autoimmune exocrinopathy)V Strand, N Talal
Pageof 15

Showing results (11-20 of 150) with videos related to

Sort By:
Pageof 15
Current Opinion in Rheumatology|September 30, 1999
Biologic agents and innovative interventional approaches in the management of systemic lupus erythematosusV Strand
Clinical and Experimental Rheumatology|November 2, 1999
Steroid withdrawal favours joint erosion in rheumatoid arthritisV Strand
Lupus|April 24, 2001
Monoclonal antibodies and other biologic therapiesV Strand
The Journal of Rheumatology|July 1, 1995
OMERACT II: the biologics perspectiveV Strand
Springer Seminars in Immunopathology|July 18, 2001
New therapies in development for autoimmune diseases: their rationale for combination treatmentV Strand
Bailliere'S Clinical Rheumatology|November 1, 1995
Innovative treatment approaches for rheumatoid arthritis. Issues in clinical trials of biological agentsV Strand
Current Rheumatology Reports|December 26, 2001
Radiography of rheumatoid arthritis in the time of increasing drug effectivenessF Wolfe, V Strand
Rheumatology (Oxford, England)|March 18, 2004
Efficacy and safety of leflunomide 10 mg versus 20 mg once daily in patients with active rheumatoid arthritis: multinational double-blind, randomized trialG Poór, V Strand,
Internal Medicine Journal|October 15, 2013
Biosimilars: how similar?V Strand, B Cronstein
Bulletin on the Rheumatic Diseases|January 1, 1979
Advances in the diagnosis and concept of Sjögren's syndrome (autoimmune exocrinopathy)V Strand, N Talal
Pageof 15